Natixis Advisors, L.P. Liva Nova PLC Transaction History

Natixis Advisors, L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 10, 2020	SELL	$68.92 - $85.27 $2.12 Million - $2.63 Million	-30,829 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$71.74 - $86.35 $5,810 - $6,994	-81 Reduced 0.26%	30,829 $2.27 Million
Q2 2019 Aug 12, 2019	SELL	$66.45 - $97.36 $41,863 - $61,336	-630 Reduced 2.0%	30,910 $2.22 Million
Q1 2019 May 15, 2019	BUY	$86.15 - $100.49 $87,011 - $101,494	1,010 Added 3.31%	31,540 $3.07 Million
Q4 2018 Feb 13, 2019	SELL	$84.14 - $125.42 $806,229 - $1.2 Million	-9,582 Reduced 23.89%	30,530 $2.79 Million
Q3 2018 Nov 13, 2018	SELL	$101.02 - $130.95 $1.55 Million - $2 Million	-15,308 Reduced 27.62%	40,112 $4.97 Million
Q2 2018 Aug 14, 2018	SELL	$81.75 - $105.37 $85,183 - $109,795	-1,042 Reduced 1.85%	55,420 $0
Q1 2018 May 10, 2018	SELL	$79.95 - $89.74 $107,692 - $120,879	-1,347 Reduced 2.33%	56,462 $5 Million
Q4 2017 Feb 14, 2018	BUY	$71.8 - $88.21 $4.15 Million - $5.1 Million	57,809	57,809 $4.62 Million

262

53M

316K

127K

Ticker LIVN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 53,545,700
Market Cap $2.76B
Description
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

Stay updated on Natixis Advisors, L.P. with notifications on news.